Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-2-24
pubmed:abstractText
This study investigated if long-term treatment with high-dose mesalamine reduces the risk of clinical relapse of Crohn's disease after surgical resection.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0016-5085
pubmed:author
pubmed:issnType
Print
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
264-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10648454-Adult, pubmed-meshheading:10648454-Aged, pubmed-meshheading:10648454-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:10648454-Crohn Disease, pubmed-meshheading:10648454-Double-Blind Method, pubmed-meshheading:10648454-Europe, pubmed-meshheading:10648454-Female, pubmed-meshheading:10648454-Follow-Up Studies, pubmed-meshheading:10648454-Humans, pubmed-meshheading:10648454-Male, pubmed-meshheading:10648454-Mesalamine, pubmed-meshheading:10648454-Middle Aged, pubmed-meshheading:10648454-Placebos, pubmed-meshheading:10648454-Proportional Hazards Models, pubmed-meshheading:10648454-Prospective Studies, pubmed-meshheading:10648454-Recurrence, pubmed-meshheading:10648454-Risk Factors, pubmed-meshheading:10648454-Time Factors, pubmed-meshheading:10648454-Treatment Outcome
pubmed:year
2000
pubmed:articleTitle
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
pubmed:affiliation
IV Medizinische Klinik, Universitätsklinikum Charité, Humboldt Universität, Berlin, Germany. herbet.lochs@charite.de
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study